Source Paper
Neural stem cell mediated recovery is enhanced by Chondroitinase ABC pretreatment in chronic cervical spinal cord injury
Hidenori Suzuki, Christopher S. Ahuja, et al.
Source Paper
Hidenori Suzuki, Christopher S. Ahuja, et al.
PLoS ONE • 2017
Traumatic spinal cord injuries (SCIs) affect millions of people worldwide; the majority of whom are in the chronic phase of their injury. Unfortunately, most current treatments target the acute/subacute injury phase as the microenvironment of chronically injured cord consists of a well-established glial scar with inhibitory chondroitin sulfate proteoglycans (CSPGs) which acts as a potent barrier to regeneration. It has been shown that CSPGs can be degraded in vivo by intrathecal Chondroitinase ABC (ChABC) to produce a more permissive environment for regeneration by endogenous cells or transplanted neural stem cells (NSCs) in the subacute phase of injury. Using a translationally-relevant clip-contusion model of cervical spinal cord injury in mice we sought to determine if ChABC pretreatment could modify the harsh chronic microenvironment to enhance subsequent regeneration by induced pluripotent stem cell-derived NSCs (iPS-NSC). Seven weeks after injury-during the chronic phase-we delivered ChABC by intrathecal osmotic pump for one week followed by intraparenchymal iPS-NSC transplant rostral and caudal to the injury epicenter. ChABC administration reduced chronic-injury scar and resulted in significantly improved iPSC-NSC survival with clear differentiation into all three neuroglial lineages. Neurons derived from transplanted cells also formed functional synapses with host circuits on patch clamp analysis. Furthermore, the combined treatment led to recovery in key functional muscle groups including forelimb grip strength and measures of forelimb/hindlimb locomotion assessed by Catwalk. This represents important proof-of-concept data that the chronically injured spinal cord can be 'unlocked' by ChABC pretreatment to produce a microenvironment conducive to regenerative iPS-NSC therapy.
Objective: Assessment of forelimb grip strength to measure motor function recovery in mice following spinal cord injury
Gather these items before starting the experiment. Check off items as you prepare.
1 item available from ConductScience
Estimated: $2,900.00
As an Amazon Associate, we earn from qualifying purchases. Product links help support this free resource.
Obtain 70 adult female wild-type C57BL/6 mice aged 8-10 weeks weighing 15-20g from Jackson Laboratories
“A total of 70 adult (8–10 weeks old), female, wild-type C57BL/6 mice (15 to 20g) from Jackson Laboratories”
Measure grip strength at baseline (6 weeks post-injury) before randomization into treatment groups
Note: No statistically significant differences between groups at this timepoint
“Grip strength measurements at six weeks were not statistically different between groups (ANOVA; p = 0.871)”
Randomize 60 injured mice into four experimental groups: control, ChABC, iPS-NSCs, and ChABC + iPS-NSCs
“Six weeks after injury, mice were randomized into four experimental groups (control, ChABC, iPS-NSCs, & ChABC + iPS-NSCs)”
Implant mini-osmotic pump rostral to the injury site under anesthesia
“Seven weeks post-injury, a mini-osmotic pump was implanted rostral to the injury site”
Deliver either ChABC in aCSF or aCSF alone via implanted mini-osmotic pump
“The pump delivered either Chondroitinase ABC (ChABC) in artificial cerebral spinal fluid (aCSF) or aCSF alone”
Remove mini-osmotic pump after one week of treatment delivery
“One week later the pump was explanted”
Transplant iPS-NSCs into spinal cord parenchyma at four sites (two rostral, two caudal), delivering 50,000 cells in 1 μL per site
“induced pluripotent stem cell-derived neural stem cells (iPS-NSC) were transplanted into the cord parenchyma at two rostral and two caudal sites. 50,000 cells in 1 μL were delivered to each site”
Administer Cyclosporine A immunosuppression starting 2 days prior to cell transplantation
“Cyclosporine A immunosuppression was delivered from 2 days prior to transplantation until the end of the study”
Perform behavioral assessments including grip strength measurements throughout the study period
“Behavioral assessments were performed across all 16 weeks of the study”
Conduct electrophysiologic assessments at end of study
“At 16 weeks electrophysiologic assessments were completed”
Perform whole-animal perfusion, fixation, and immunohistochemical analyses
“followed by whole-animal perfusion, fixation and immunohistochemical analyses”
Adult wild-type mice
Evidence-Based
19 quotes from paper
No institutional citation data available yet.